Table 2.
The correlation between BMI and disease activity and function at baseline in patients with PsA and obesity (N = 41)
| Spearman’s rho | p value | |
|---|---|---|
| CRP, mg/L | 0.312 | 0.047 |
| Tender joints 68, score | 0.333 | 0.034 |
| Swollen joints 66, score | − 0.139 | 0.385 |
| VAS patients global disease activity, mm | 0.370 | 0.017 |
| VAS pain, mm | 0.298 | 0.059 |
| VAS fatigue, mm | 0.220 | 0.168 |
| DAS28CRP, score | 0.382 | 0.014 |
| DAPSA, score | 0.360 | 0.021 |
| Leeds enthesitis index, score | 0.483 | 0.001 |
| BSA, % | −0.155 | 0.334 |
| HAQ, score | 0.457 | 0.003 |
| DLQI, score | −0.113 | 0.483 |
BMI body mass index, BSA body surface area, CRP C-reactive protein, DAPSA Disease Activity in PSoriatic Arthritis, DAS28CRP Disease Activity Score using 28 joint counts based on CRP, DLQI Dermatology Life Quality Index, VAS visual analogue scale